3.26.1 html 175 278 1 true 47 0 false 6 false false R1.htm 75000 - Document - Document and Entity Information Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 75010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 75020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 75030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 4 false false R5.htm 75050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 75060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 7 false false R8.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 8 false false R9.htm 995455 - Disclosure - Operations Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureOperations Operations Notes 9 false false R10.htm 995465 - Disclosure - Summary of Significant Accounting Policies Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 995475 - Disclosure - Revenue Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureRevenue Revenue Notes 11 false false R12.htm 995485 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://eyepointpharma.com/20260630/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssets Prepaid Expenses and Other Current Assets Notes 12 false false R13.htm 995495 - Disclosure - Inventory Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureInventory Inventory Notes 13 false false R14.htm 995505 - Disclosure - Accrued Expenses Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureAccruedExpenses Accrued Expenses Notes 14 false false R15.htm 995515 - Disclosure - Leases Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureLeases Leases Notes 15 false false R16.htm 995535 - Disclosure - Stockholders' Equity Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureStockholdersEquity Stockholders' Equity Notes 16 false false R17.htm 995545 - Disclosure - Share-Based Payment Awards Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureShareBasedPaymentAwards Share-Based Payment Awards Notes 17 false false R18.htm 995575 - Disclosure - Fair Value Measurements Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureFairValueMeasurements Fair Value Measurements Notes 18 false false R19.htm 995585 - Disclosure - Segment Information Sheet http://eyepointpharma.com/20260630/taxonomy/role/DisclosureSegmentInformation Segment Information Notes 19 false false R20.htm 995595 - Disclosure - Contingencies Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureContingencies Contingencies Notes 20 false false R21.htm 995605 - Disclosure - Net Loss per Share Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureNetLossPerShare Net Loss per Share Notes 21 false false R22.htm 995625 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://eyepointpharma.com/20260630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies 22 false false R23.htm 995645 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://eyepointpharma.com/20260630/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables http://eyepointpharma.com/20260630/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssets 23 false false R24.htm 995655 - Disclosure - Inventory (Tables) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureInventoryTables Inventory (Tables) Tables http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureInventory 24 false false R25.htm 995665 - Disclosure - Accrued Expenses (Tables) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureAccruedExpensesTables Accrued Expenses (Tables) Tables http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureAccruedExpenses 25 false false R26.htm 995675 - Disclosure - Leases (Tables) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureLeasesTables Leases (Tables) Tables http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureLeases 26 false false R27.htm 995695 - Disclosure - Share-Based Payment Awards (Tables) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureShareBasedPaymentAwardsTables Share-Based Payment Awards (Tables) Tables http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureShareBasedPaymentAwards 27 false false R28.htm 995715 - Disclosure - Fair Value Measurements (Tables) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureFairValueMeasurements 28 false false R29.htm 995725 - Disclosure - Segment Information (Tables) Sheet http://eyepointpharma.com/20260630/taxonomy/role/DisclosureSegmentInformationTables Segment Information (Tables) Tables http://eyepointpharma.com/20260630/taxonomy/role/DisclosureSegmentInformation 29 false false R30.htm 995735 - Disclosure - Net Loss per Share (Tables) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureNetLossPerShareTables Net Loss per Share (Tables) Tables http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureNetLossPerShare 30 false false R31.htm 995745 - Disclosure - Operations - Additional Information (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureOperationsAdditionalInformationDetail Operations - Additional Information (Detail) Details 31 false false R32.htm 995755 - Disclosure - Revenue - Additional Information (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetail Revenue - Additional Information (Detail) Details 32 false false R33.htm 995775 - Disclosure - Prepaid Expenses and Other Current Assets - Schedule of Prepaid Expenses and Other Current Assets (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail Prepaid Expenses and Other Current Assets - Schedule of Prepaid Expenses and Other Current Assets (Detail) Details 33 false false R34.htm 995785 - Disclosure - Prepaid Expenses and Other Current Assets - Additional Information (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsAdditionalInformationDetail Prepaid Expenses and Other Current Assets - Additional Information (Detail) Details 34 false false R35.htm 995795 - Disclosure - Inventory - Schedule of Inventory (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureInventoryScheduleOfInventoryDetail Inventory - Schedule of Inventory (Detail) Details 35 false false R36.htm 995805 - Disclosure - Inventory - Additional Information (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/DisclosureInventoryAdditionalInformationDetail Inventory - Additional Information (Detail) Details 36 false false R37.htm 995815 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetail Accrued Expenses - Schedule of Accrued Expenses (Detail) Details 37 false false R38.htm 995825 - Disclosure - Leases - Additional Information (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail Leases - Additional Information (Detail) Details 38 false false R39.htm 995835 - Disclosure - Leases - Supplemental Balance Sheet Related to Operating Leases (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureLeasesSupplementalBalanceSheetRelatedToOperatingLeasesDetail Leases - Supplemental Balance Sheet Related to Operating Leases (Detail) Details 39 false false R40.htm 995845 - Disclosure - Leases - Summary of Lease Expense (Details) Sheet http://eyepointpharma.com/20260630/taxonomy/role/DisclosureLeasesSummaryOfLeaseExpenseDetails Leases - Summary of Lease Expense (Details) Details 40 false false R41.htm 995855 - Disclosure - Leases - Schedule of Future Minimum Lease Payments Under Non-Cancellable Leases (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancellableLeasesDetail Leases - Schedule of Future Minimum Lease Payments Under Non-Cancellable Leases (Detail) Details 41 false false R42.htm 995895 - Disclosure - Stockholders' Equity - Equity Financings - Additional Information (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/DisclosureStockholdersEquityEquityFinancingsAdditionalInformationDetail Stockholders' Equity - Equity Financings - Additional Information (Detail) Details 42 false false R43.htm 995905 - Disclosure - Stockholders' Equity - Warrants to Purchase Common Shares - Additional Information (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureStockholdersEquityWarrantsToPurchaseCommonSharesAdditionalInformationDetail Stockholders' Equity - Warrants to Purchase Common Shares - Additional Information (Detail) Details 43 false false R44.htm 995915 - Disclosure - Share-Based Payment Awards - Equity Incentive Plan - Additional Information (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureShareBasedPaymentAwardsEquityIncentivePlanAdditionalInformationDetail Share-Based Payment Awards - Equity Incentive Plan - Additional Information (Detail) Details 44 false false R45.htm 995925 - Disclosure - Share-Based Payment Awards - Stock Option Activity Under Company's Equity Incentive Plan (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureShareBasedPaymentAwardsStockOptionActivityUnderCompanySEquityIncentivePlanDetail Share-Based Payment Awards - Stock Option Activity Under Company's Equity Incentive Plan (Detail) Details 45 false false R46.htm 995935 - Disclosure - Share-Based Payment Awards - Stock Options and Performance Options - Additional Information (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/DisclosureSharebasedPaymentAwardsStockOptionsAndPerformanceOptionsAdditionalInformationDetail Share-Based Payment Awards - Stock Options and Performance Options - Additional Information (Detail) Details 46 false false R47.htm 995945 - Disclosure - Share-Based Payment Awards - Summary of Company Applied the Black-Scholes Option Pricing (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureShareBasedPaymentAwardsSummaryOfCompanyAppliedBlackScholesOptionPricingDetail Share-Based Payment Awards - Summary of Company Applied the Black-Scholes Option Pricing (Detail) Details 47 false false R48.htm 995955 - Disclosure - Share-Based Payment Awards - Summary of Information about Stock Options (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureShareBasedPaymentAwardsSummaryOfInformationAboutStockOptionsDetail Share-Based Payment Awards - Summary of Information about Stock Options (Detail) Details 48 false false R49.htm 995965 - Disclosure - Share-Based Payment Awards - Time-Vested Restricted Stock Units - Additional Information (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureShareBasedPaymentAwardsTimeVestedRestrictedStockUnitsAdditionalInformationDetail Share-Based Payment Awards - Time-Vested Restricted Stock Units - Additional Information (Detail) Details 49 false false R50.htm 995975 - Disclosure - Share-Based Payment Awards - Summary of Restricted Stock Unit Activity (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureShareBasedPaymentAwardsSummaryOfRestrictedStockUnitActivityDetail Share-Based Payment Awards - Summary of Restricted Stock Unit Activity (Detail) Details 50 false false R51.htm 995985 - Disclosure - Share-Based Payment Awards - Employee Stock Purchase Plan - Additional Information (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureShareBasedPaymentAwardsEmployeeStockPurchasePlanAdditionalInformationDetail Share-Based Payment Awards - Employee Stock Purchase Plan - Additional Information (Detail) Details 51 false false R52.htm 995995 - Disclosure - Share-Based Payment Awards - Compensation Expense from Stock-Based Payment Awards (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureShareBasedPaymentAwardsCompensationExpenseFromStockBasedPaymentAwardsDetail Share-Based Payment Awards - Compensation Expense from Stock-Based Payment Awards (Detail) Details 52 false false R53.htm 996005 - Disclosure - Share-Based Payment Awards - Stock-Based Compensation Expense - Additional Information (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureShareBasedPaymentAwardsStockBasedCompensationExpenseAdditionalInformationDetail Share-Based Payment Awards - Stock-Based Compensation Expense - Additional Information (Detail) Details 53 false false R54.htm 996015 - Disclosure - License and Asset Purchase Agreements - Additional Information (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureLicenseAndAssetPurchaseAgreementsAdditionalInformationDetail License and Asset Purchase Agreements - Additional Information (Detail) Details 54 false false R55.htm 996045 - Disclosure - Fair Value Measurements - Assets and Liabilities Carried at Fair Value Measured on Recurring Basis (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureFairValueMeasurementsAssetsAndLiabilitiesCarriedAtFairValueMeasuredOnRecurringBasisDetail Fair Value Measurements - Assets and Liabilities Carried at Fair Value Measured on Recurring Basis (Detail) Details 55 false false R56.htm 996055 - Disclosure - Fair Value Measurements - Additional Information (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetail Fair Value Measurements - Additional Information (Detail) Details 56 false false R57.htm 996065 - Disclosure - Segment Information - Segment and Geographic Area Information (Details) Sheet http://eyepointpharma.com/20260630/taxonomy/role/DisclosureSegmentInformationSegmentAndGeographicAreaInformationDetails Segment Information - Segment and Geographic Area Information (Details) Details 57 false false R58.htm 996075 - Disclosure - Segment Information - Additional Information (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetail Segment Information - Additional Information (Detail) Details 58 false false R59.htm 996085 - Disclosure - Contingencies - Additional Information (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/DisclosureContingenciesAdditionalInformationDetail Contingencies - Additional Information (Detail) Details 59 false false R60.htm 996095 - Disclosure - Net Loss per Share - Potentially Dilutive Securities Excluded from Computation of Diluted Weighted-Average Shares (Detail) Sheet http://eyepointpharma.com/20260630/taxonomy/role/Role_DisclosureNetLossPerSharePotentiallyDilutiveSecuritiesExcludedFromComputationOfDilutedWeightedAverageSharesDetail Net Loss per Share - Potentially Dilutive Securities Excluded from Computation of Diluted Weighted-Average Shares (Detail) Details 60 false false All Reports Book All Reports eypt-20260630.htm eypt-20260630.xsd http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 false false